These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 30128024)
21. Efficiency Optimization of CRISPR/Cas9-Mediated Targeted Mutagenesis in Grape. Ren F; Ren C; Zhang Z; Duan W; Lecourieux D; Li S; Liang Z Front Plant Sci; 2019; 10():612. PubMed ID: 31156675 [TBL] [Abstract][Full Text] [Related]
22. A rapid method for detection of mutations induced by CRISPR/Cas9-based genome editing in common wheat. Kamiya Y; Abe F; Mikami M; Endo M; Kawaura K Plant Biotechnol (Tokyo); 2020 Jun; 37(2):247-251. PubMed ID: 32821233 [TBL] [Abstract][Full Text] [Related]
23. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins. Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL mBio; 2017 Nov; 8(6):. PubMed ID: 29114029 [TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-Mediated α-ENaC Knockout in a Murine Pancreatic β-Cell Line. Zhang X; Zhao L; Jin R; Li M; Li MS; Li R; Liang X Front Genet; 2021; 12():664799. PubMed ID: 33868391 [TBL] [Abstract][Full Text] [Related]
25. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system. Bevacqua RJ; Fernandez-Martín R; Savy V; Canel NG; Gismondi MI; Kues WA; Carlson DF; Fahrenkrug SC; Niemann H; Taboga OA; Ferraris S; Salamone DF Theriogenology; 2016 Nov; 86(8):1886-1896.e1. PubMed ID: 27566851 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Apoptosis, Cell Proliferation and Cell Cycle Progression by Inactivation of the NEAT1 Long Noncoding RNA in a Renal Carcinoma Cell Line Using CRISPR/Cas9. Haghighi N; Doosti A; Kiani J Iran J Biotechnol; 2023 Jan; 21(1):e3180. PubMed ID: 36811109 [TBL] [Abstract][Full Text] [Related]
27. Dynamics of CRISPR/Cas9-mediated genomic editing of the Scharf I; Bierbaumer L; Huber H; Wittmann P; Haider C; Pirker C; Berger W; Mikulits W Oncol Lett; 2018 Feb; 15(2):2441-2450. PubMed ID: 29434956 [TBL] [Abstract][Full Text] [Related]
29. Functional characterization of Pol III U6 promoters for gene knockdown and knockout in Plutella xylostella. Huang Y; Wang Y; Zeng B; Liu Z; Xu X; Meng Q; Huang Y; Yang G; Vasseur L; Gurr GM; You M Insect Biochem Mol Biol; 2017 Oct; 89():71-78. PubMed ID: 28890398 [TBL] [Abstract][Full Text] [Related]
30. A simple and efficient cloning system for CRISPR/Cas9-mediated genome editing in rice. Liu X; Zhou X; Li K; Wang D; Ding Y; Liu X; Luo J; Fang C PeerJ; 2020; 8():e8491. PubMed ID: 32030327 [TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-Editing K562 Cell Line as a Potential Tool in Transfusion Applications: Knockout of Vel Antigen Gene. Yang J; Li A; Li M; Ruan S; Ye L Transfus Med Hemother; 2024 Aug; 51(4):265-273. PubMed ID: 39021420 [TBL] [Abstract][Full Text] [Related]
32. Customized one-step preparation of sgRNA transcription templates via overlapping PCR Using short primers and its application in vitro and in vivo gene editing. Hu Z; Wang L; Shi Z; Jiang J; Li X; Chen Y; Li K; Luo D Cell Biosci; 2019; 9():87. PubMed ID: 31673328 [TBL] [Abstract][Full Text] [Related]
33. Large-scale single-cell cloning of genome-edited cultured human cells by On-chip SPiS. Takahashi G; Miyaoka Y STAR Protoc; 2023 Sep; 4(3):102364. PubMed ID: 37329509 [TBL] [Abstract][Full Text] [Related]
34. Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments. Kimberland ML; Hou W; Alfonso-Pecchio A; Wilson S; Rao Y; Zhang S; Lu Q J Biotechnol; 2018 Oct; 284():91-101. PubMed ID: 30142414 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles. Alinejad T; Modarressi S; Sadri Z; Hao Z; Chen CS J Cancer Res Clin Oncol; 2023 Sep; 149(12):9557-9575. PubMed ID: 37222810 [TBL] [Abstract][Full Text] [Related]
36. Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox. Azlan A; Rajasegaran Y; Kang Zi K; Rosli AA; Yik MY; Yusoff NM; Heidenreich O; Moses EJ Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453665 [TBL] [Abstract][Full Text] [Related]
37. Establishment of an miR-137-knockout cell model using CRISPR/Cas9 genome editing. Chen W; Li Q; Du J; Li X; Jiang S; He Y Oncol Lett; 2018 Sep; 16(3):4027-4032. PubMed ID: 30128024 [TBL] [Abstract][Full Text] [Related]
38. [Construction of all-in-one CRISPR/Cas9 vector system targeting miR-101a gene in mouse hepatic cell line AML12]. Chen D; Li Y Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 46(4):427-432. PubMed ID: 29256233 [TBL] [Abstract][Full Text] [Related]
39. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. Huo W; Zhao G; Yin J; Ouyang X; Wang Y; Yang C; Wang B; Dong P; Wang Z; Watari H; Chaum E; Pfeffer LM; Yue J J Cancer; 2017; 8(1):57-64. PubMed ID: 28123598 [TBL] [Abstract][Full Text] [Related]
40. Efficient CRISPR/Cas9-Mediated Gene Editing in an Interspecific Hybrid Poplar With a Highly Heterozygous Genome. Wang J; Wu H; Chen Y; Yin T Front Plant Sci; 2020; 11():996. PubMed ID: 32719704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]